Navigation Links
Telik Announces Initiation of Phase 1 Clinical Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets in Combination With Lenalidomide (Revlimid(R)) in Patients With Myelodysplastic Syndrome (MDS)
Date:1/25/2010

s with Severe Chronic Idiopathic Neutropenia (SCIN).

Background on MDS and TELINTRA

MDS is a heterogeneous group of blood stem cell disorders of increasing incidence.  MDS is characterized by ineffective blood cell production involving one or more of the red cell, white cell or platelet lineages and with MDS patients having a variable risk of progression to leukemia.  There remains a need for effective, well tolerated therapies for MDS having novel mechanisms of action.  TELINTRA has a novel mechanism of action that inhibits a target enzyme called glutathione S-transferase P1-1 which in turn facilitates the activation of JNK kinase, a key regulator of cellular growth and differentiation of blood.  TELINTRA has been shown to stimulate normal multilineage differentiation of blood stem cell precursors and induce cancer cell death in human leukemia cell lines.  Additional information on TELINTRA is available at www.telik.com.

About Telik

Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering and developing small molecule drugs to treat cancer and inflammatory diseases.  The company's most advanced investigational drug candidates in clinical development are TELINTRA, a modified glutathione analog for the treatment of cytopenias due to myelodysplastic syndrome or chemotherapy, and TELCYTA®, a tumor-activated prodrug for the treatment of advanced ovarian cancer and non-small cell lung cancer.  Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP®, which enables the rapid and efficient discovery of small molecule drug candidates.


'/>"/>
SOURCE Telik, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Telik Announces Presentation of Preclinical Data on Dual Inhibitors of Aurora Kinases and VEGFR2
2. Telik Announces Preclinical Data Demonstrating Anti-Cancer Activity of Dual Inhibitors of Aurora Kinase and VEGFR2
3. Telik Announces Telintra Presentation at American Society of Hematology Annual Meeting
4. Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies
5. Teliks Proteasome Inhibitor Program Meets a Preclinical Development Milestone
6. Telik Announces Presentation at ASCO Annual Meeting
7. Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome
8. Telik Announces Publication of Positive Phase 1-2a Results of a Multicenter Study of TELCYTA(R) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer
9. Telik Announces Third Quarter 2009 Financial Results
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... , May 4, 2015  BioSpecifics Technologies Corp. ... in class collagenase-based products marketed as XIAFLEX ® ... XIAPEX ®  in the EU, will announce its first ... U.S. financial markets on Monday, May 11, 2015 and ... a.m. ET the next day, Tuesday May 12, 2015.  ...
(Date:5/4/2015)... 2015 Microbrush International, a leading developer, producer ... restorative procedures, today announced the acquisition of DentiSmart ... sectional matrix system used in dental restorative procedures. ... opportunity to add DentiSmart to our growing portfolio ... VP and General Manager of Microbrush. "DentiSmart,s products ...
(Date:5/4/2015)... , May 4, 2015   The New York ... Kybella, from internationally acclaimed plastic surgeon, Dr. Rod ... Drug Administration, is proven to reduce fat deposits under ... The active ingredient in Kybella, deoxycholic ... plastic surgeons the ability to reshape this area without ...
Breaking Medicine Technology:BioSpecifics Technologies Corp. to Report First Quarter 2015 Financial Results on Monday, May 11, 2015 2Microbrush International Announces Acquisition of DentiSmart 2Dr. Rod Rohrich Provides Medical Expertise on Kybella 2Dr. Rod Rohrich Provides Medical Expertise on Kybella 3
... Dec. 7, 2010 LABS Inc., the premier transplant ... that Kevin M. Smith, Chief Operating Officer of the ... has joined the company,s Board of Directors.  Smith brings ... industries. In addition to his current role ...
... 80 percent of the surgeries performed in the U.S. put patients ... a brain monitor is not used by the anesthesiologist. ... book recently published by Dr. Barry Friedberg, an acclaimed anesthesiologist who ... in Michael Jackson,s death. "The simple use of a ...
Cached Medicine Technology:LABS Inc. Adds Life Sciences Industry Veteran Kevin M. Smith to Board of Directors 2Michael Jackson's Death Could Have Been Avoided With a Brain Monitor Says Anesthesiologist 2
(Date:5/5/2015)... AR (PRWEB) May 05, 2015 ... is collaborating with American Eagle Outfitters on a ... enhance natural beauty. , For the debut ... with Aerie by American Eagle ; the ... brand's body-image campaign, called "Aerie REAL," uses models ...
(Date:5/5/2015)... May 05, 2015 May is National Osteoporosis ... Institute for Better Bone Health . Founded by Charles ... to educate both consumers and physicians about the latest advances ... bone health. , According to a study recently published by ... Americans are affected by osteoporosis and low bone mass. This ...
(Date:5/5/2015)... NovaSom, Inc., announced today that they ... with Ed Begley Jr., airing via Discovery Channel 3rd ... segment will focus on NovaSom, a leader in Obstructive ... their AccuSom® home sleep test, which is the only ... support and next-day test results and interpretation. , ...
(Date:5/5/2015)... 05, 2015 Care Logistics ... called “Medicare Breakeven Challenges? A Model to ... ,     Formulas for two critical ... but should be ,     A model ... space” and ensures sustained efficient operations , ...
(Date:5/5/2015)... Crawford Technologies announced today it has been awarded ... of the Business Marketing Association (BMA) for the redesign ... was presented to the CrawfordTech marketing team on Friday, May ... over 300 people in attendance. , “The launch of the ... a shift in focus for how our company communicates our ...
Breaking Medicine News(10 mins):Health News:BLKBOXLabs Finds Real Beauty in Beauty For Real and American Eagle Outfitters’ Aerie-Branded Beauty Line 2Health News:BLKBOXLabs Finds Real Beauty in Beauty For Real and American Eagle Outfitters’ Aerie-Branded Beauty Line 3Health News:The Institute for Better Bone Health Observes National Osteoporosis Month, Celebrates Three Years of Promoting Healthy Bones 2Health News:The Institute for Better Bone Health Observes National Osteoporosis Month, Celebrates Three Years of Promoting Healthy Bones 3Health News:Innovations with Ed Begley, Jr. to Explore NovaSom, Inc., in Upcoming Episode 2Health News:Care Logistics Publishes a New Hospital Guidebook for Achieving Medicare Breakeven 2Health News:Crawford Technologies Awarded BMA’s ‘2015 Gold Key Award’ for Innovative Website Redesign 2Health News:Crawford Technologies Awarded BMA’s ‘2015 Gold Key Award’ for Innovative Website Redesign 3
... OMRON HEALTHCARE Co., Ltd., a,subsidiary of Omron ... home,healthcare, and wellness products, has developed the ... release worldwide in,spring 2009., "HEM-SOLAR monitors ... blood pressure readings wherever sunlight is available," ...
... Renew Acclaimed Series, NEW YORK, March 12 ... of Life" are being inundated with calls,blogs, e-mails, faxes ... renewed. These are not just ordinary fans. Many of ... survivors who are not,used to giving up a fight. ...
... watch TVs or computers, study finds , , WEDNESDAY, March 12 ... far too many hours a week in front of TVs ... "screen time." , "The take-home message is that we have ... healthier alternatives in their neighborhoods," said study author Tracie A. ...
... 12 The Providence,Service Corporation (Nasdaq: PRSC ) ... statement for shares of its common stock on Form ... anticipates,that it will file the proposed shelf registration statement ... 10-K for the Year Ended,December 31, 2007; however, it ...
... the Johns Hopkins Kimmel Cancer Center have uncovered,clearly recognizable ... early-stage lung cancers that look like good,predictors of which ... The discovery, they say, could change the approach to ... a pea - which are known to recur,within five ...
... Do you remember the seventh song that played on ... us dont, thanks to a normal forgetting process that is ... Researchers at the Buck Institute now believe that this normal ... this effect is key to the profound memory loss associated ...
Cached Medicine News:Health News:Omron Healthcare Develops Solar-Powered Digital Blood Pressure Monitors 2Health News:Omron Healthcare Develops Solar-Powered Digital Blood Pressure Monitors 3Health News:Cancer Survivors Lobby Lifetime TV to Order More of 'Side Order of Life' 2Health News:Teens Spending Too Much Screen Time 2Health News:Providence Service Corporation Announces Intent to File a Common Stock Shelf Registration Statement 2Health News:DNA detectives find genetic markers for lung cancers most likely to recur 2Health News:Paradoxical Alzheimer's finding may shed new light on memory loss 2
The 81483N projector operates off of DC power for maximum portability. The 20 watt halogen bulb with a specially designed reflector provides maximum brightness and portability....
Integrated electronics, single-chip CCD camera with PAL and NTSC output. PAL output at 460 lines, NTSC output at 470 lines, focal length 30mm. 90mm length x 20mm diameter....
High intensity halogen lamp with built-in, switchable spare. Optical light concentrator to optimize existing light energy....
... biocompatible, flexible, one-piece artificial cornea (keratoprosthesis) designed ... cornea., ,The World Health Organisation (WHO) reports ... million people worldwide, however only 100,000 people ... is due to a combination of inadequate ...
Medicine Products: